ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 72 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $149,000 | -57.5% | 25,865 | 0.0% | 0.01% | -45.0% |
| Q3 2018 | $351,000 | +14.3% | 25,865 | 0.0% | 0.02% | +5.3% |
| Q2 2018 | $307,000 | +5.5% | 25,865 | 0.0% | 0.02% | 0.0% |
| Q1 2018 | $291,000 | -64.5% | 25,865 | -78.9% | 0.02% | -63.5% |
| Q4 2017 | $819,000 | -18.4% | 122,644 | 0.0% | 0.05% | -16.1% |
| Q3 2017 | $1,004,000 | +19.8% | 122,644 | -34.3% | 0.06% | +10.7% |
| Q2 2017 | $838,000 | -22.3% | 186,578 | -4.6% | 0.06% | -24.3% |
| Q1 2017 | $1,078,000 | – | 195,571 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |